Natalie Bezman

3.2k total citations
45 papers, 2.2k citations indexed

About

Natalie Bezman is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Natalie Bezman has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 14 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in Natalie Bezman's work include Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (14 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Natalie Bezman is often cited by papers focused on Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (14 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Natalie Bezman collaborates with scholars based in United States, Slovakia and Germany. Natalie Bezman's co-authors include Lewis L. Lanier, Joseph C. Sun, Joshua Beilke, Sharline Madera, Timothy P. Bender, Tirtha Chakraborty, Gary A. Koretzky, Mark H. Kaplan, Gundula Min‐Oo and Jeremy Thorner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Natalie Bezman

44 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalie Bezman United States 25 1.3k 757 522 411 322 45 2.2k
Douglas C. Saffran United States 17 1.9k 1.4× 890 1.2× 509 1.0× 209 0.5× 604 1.9× 33 3.2k
Luigi Scotto United States 30 1.1k 0.8× 1.5k 2.0× 642 1.2× 280 0.7× 170 0.5× 82 2.8k
Laurence Lamy United States 14 679 0.5× 1.3k 1.7× 487 0.9× 337 0.8× 497 1.5× 20 2.1k
Giorgia Simonetti Italy 25 778 0.6× 1.0k 1.4× 520 1.0× 354 0.9× 377 1.2× 91 2.2k
Karen Clise-Dwyer United States 23 1.1k 0.8× 795 1.1× 781 1.5× 359 0.9× 248 0.8× 54 2.2k
Karin Reif United Kingdom 22 1.7k 1.3× 1.2k 1.5× 761 1.5× 207 0.5× 107 0.3× 29 2.7k
Viia Valge-Archer United Kingdom 19 1.2k 0.9× 1.1k 1.5× 1.0k 2.0× 373 0.9× 101 0.3× 27 2.4k
Francesca Colizzi Italy 23 881 0.7× 1.3k 1.7× 537 1.0× 216 0.5× 127 0.4× 40 1.8k
Marialuisa Sensi Italy 27 1.8k 1.4× 1.4k 1.9× 1.1k 2.2× 287 0.7× 129 0.4× 92 2.9k
Raymond Frade France 25 689 0.5× 551 0.7× 548 1.0× 298 0.7× 180 0.6× 72 1.6k

Countries citing papers authored by Natalie Bezman

Since Specialization
Citations

This map shows the geographic impact of Natalie Bezman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Bezman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Bezman more than expected).

Fields of papers citing papers by Natalie Bezman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Bezman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Bezman. The network helps show where Natalie Bezman may publish in the future.

Co-authorship network of co-authors of Natalie Bezman

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Bezman. A scholar is included among the top collaborators of Natalie Bezman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Bezman. Natalie Bezman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ledzewicz, Urszula, et al.. (2023). Determining optimal combination regimens for patients with multiple myeloma. European Journal of Pharmaceutical Sciences. 187. 106492–106492. 4 indexed citations
2.
Meermeier, Erin W., Seth J. Welsh, Meaghen E. Sharik, et al.. (2021). Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy. Blood Cancer Discovery. 2(4). 354–369. 67 indexed citations
3.
Huang, Richard Y.‐C., Yun Wang, Christine Bee, et al.. (2021). Higher-Order Structure Characterization of NKG2A/CD94 Protein Complex and Anti-NKG2A Antibody Binding Epitopes by Mass Spectrometry-Based Protein Footprinting Strategies. Journal of the American Society for Mass Spectrometry. 32(7). 1567–1574. 10 indexed citations
4.
Huang, Richard Y.‐C., Feng Wang, Matthew L. Wheeler, et al.. (2020). Integrated Approach for Characterizing Bispecific Antibody/Antigens Complexes and Mapping Binding Epitopes with SEC/MALS, Native Mass Spectrometry, and Protein Footprinting. Analytical Chemistry. 92(15). 10709–10716. 13 indexed citations
5.
Verkleij, Christie P.M., Marloes E.C. Broekmans, Kristine A. Frerichs, et al.. (2020). Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies. Cancers. 12(12). 3713–3713. 26 indexed citations
6.
Pazina, Tatiana, Ashley M. James, Yibin Yang, et al.. (2019). Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma. Cancer Immunology Research. 7(10). 1633–1646. 34 indexed citations
7.
Kurdi, Ahmed T., Siobhan Glavey, Natalie Bezman, et al.. (2018). Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab. Molecular Cancer Therapeutics. 17(7). 1454–1463. 70 indexed citations
8.
Gallaher, Jill, Marissa Renardy, Nessy Tania, et al.. (2018). Methods for determining key components in a mathematical model for tumor–immune dynamics in multiple myeloma. Journal of Theoretical Biology. 458. 31–46. 14 indexed citations
9.
Sun, Joseph C., Sharline Madera, Natalie Bezman, et al.. (2012). Proinflammatory cytokine signaling required for the generation of natural killer cell memory. The Journal of Experimental Medicine. 209(5). 947–954. 242 indexed citations
10.
Bezman, Natalie, Charles C. Kim, Joseph C. Sun, et al.. (2012). Molecular definition of the identity and activation of natural killer cells. Nature Immunology. 13(10). 1000–1009. 212 indexed citations
11.
Bezman, Natalie, Rebecca G. Baker, Laurie Lenox, Martha S. Jordan, & Gary A. Koretzky. (2009). Cutting Edge: Rescue of Pre-TCR but Not Mature TCR Signaling in Mice Expressing Membrane-Targeted SLP-76. The Journal of Immunology. 182(9). 5183–5187. 4 indexed citations
12.
Gargiulo, Gaetano, Samuel Lévy, Gabriele Bucci, et al.. (2009). NA-Seq: A Discovery Tool for the Analysis of Chromatin Structure and Dynamics during Differentiation. Developmental Cell. 16(3). 466–481. 46 indexed citations
13.
Bezman, Natalie, Lurong Lian, Charles S. Abrams, et al.. (2008). Requirements of SLP76 tyrosines in ITAM and integrin receptor signaling and in platelet function in vivo. The Journal of Experimental Medicine. 205(8). 1775–1788. 28 indexed citations
14.
Hickey, Michele M., Jennifer C. Lam, Natalie Bezman, W. Kimryn Rathmell, & M. Celeste Simon. (2007). von Hippel–Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2α signaling and splenic erythropoiesis. Journal of Clinical Investigation. 117(12). 3879–89. 91 indexed citations
15.
Bezman, Natalie & Gary A. Koretzky. (2007). Compartmentalization of ITAM and integrin signaling by adapter molecules. Immunological Reviews. 218(1). 9–28. 42 indexed citations
16.
Clemens, Regina A., Laurie Lenox, Taku Kambayashi, et al.. (2007). Loss of SLP-76 Expression within Myeloid Cells Confers Resistance to Neutrophil-Mediated Tissue Damage while Maintaining Effective Bacterial Killing. The Journal of Immunology. 178(7). 4606–4614. 23 indexed citations
17.
Wu, Jennifer N., Shereen Gheith, Natalie Bezman, et al.. (2006). Adhesion- and Degranulation-Promoting Adapter Protein Is Required for Efficient Thymocyte Development and Selection. The Journal of Immunology. 176(11). 6681–6689. 26 indexed citations
18.
Sebzda, Eric, Shawn M. Sweeney, Farhad Abtahian, et al.. (2006). Syk and Slp-76 Mutant Mice Reveal a Cell-Autonomous Hematopoietic Cell Contribution to Vascular Development. Developmental Cell. 11(3). 349–361. 89 indexed citations
19.
Abtahian, Farhad, Natalie Bezman, Regina A. Clemens, et al.. (2006). Evidence for the Requirement of ITAM Domains but Not SLP-76/Gads Interaction for Integrin Signaling in Hematopoietic Cells. Molecular and Cellular Biology. 26(18). 6936–6949. 63 indexed citations
20.
Rathmell, W. Kimryn, et al.. (2004). In vitro and In vivo Models Analyzing von Hippel-Lindau Disease-Specific Mutations. Cancer Research. 64(23). 8595–8603. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026